🔴 Decoy Therapeutics is trading 15.54% down in pre-market without a clear company-specific catalyst

Decoy Therapeutics is trading 15.54% down at $3.10 after no clear company-specific catalyst was identified for August 19, 2026.

• Recent Q2 results reported a $2.4 million loss and $228,000 revenue on August 12, but no fresh announcement was found.
• The latest identified company news was an August 3 intellectual-property update, not a new overnight event.
• Broader pre-market indexes were essentially flat, so macro sentiment does not clearly explain the decline.